Skip to main content
. Author manuscript; available in PMC: 2015 Jan 7.
Published in final edited form as: Am J Surg. 2012 Mar 9;203(5):649–653. doi: 10.1016/j.amjsurg.2012.01.003

Figure 2.

Figure 2

Cut-offs for tumor-positivity were established using receiver-operating characteristic curves. Tumors were considered positive for aldehyde dehydrogenase 1 expression if ≥ 25% of cells in the colorectal tumor were marker-positive and if ≥ 22% of metastatic liver tumor cells were marker-positive. Early stage refers to non-metastatic primary tumors, while late stage refers to metastatic primary tumors.